chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: fever of 38C; severe fatigue and malaise; severe fatigue and malaise; mild headache; Pain in the injection site began within a few minutes and gradually increased reaching it's maximum around 8 hours after the dose.; Neck pain was also significant; This is a spontaneous report from a contactable physician (patient). A 29-year-old female patient (pregnant: No) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number and Expiration Date unknown) via an unspecified route of administration on 05Jan2021 12:00 PM (Left arm) at single dose on arm for COVID-19 immunization. Historical Vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Dec2020 09:00 PM (Arm Right) at single dose for COVID-19 immunization. No other vaccine in four weeks. The patient's medical history included asthma and generalized anxiety disorder (GAD). The concomitant drug was reported as Escitalopram. The patient experienced pain in the injection site began within a few minutes (05Jan2021 12:15 PM) and gradually increased reaching it's maximum around 8 hours after the dose. Neck pain was also significant (05Jan2021 12:15 PM). Fatigue, malaise and mild headache started around 10 hours (05Jan2021 22:00) following vaccine administration. Almost 24 hours following administration (06Jan2021 12:00) a fever of 38 C started and persisted for about 6-8 hours. It subsided but severe fatigue and malaise (that prevent me to do daily activities) are still persisting greater than 48 hours following administration. The outcome of severe fatigue and malaise was not recovered. The outcome of Headache, Pain in the injection site, Neck pain, fever of 38 C, was recovering. No treatment received for the adverse event. No COVID prior vaccination and no COVID tested post vaccination.  Information on Lot/batch number has been requested.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Nausea
Clinical narrative: dizziness; weakness; nausea; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient non-pregnant received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E13246), via an unspecified route of administration on 06Jan2021 13:00 at single dose in right arm for covid-19 immunization. Medical history included arthritis. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications received within 2 weeks of vaccination was reported as yes. The patient experienced dizziness, weakness, nausea, diarrhea on 07Jan2021. The patient was not received any treatment. The outcome of the events was not recovered.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Off label use, Pain, Product use issue
Clinical narrative: Fever for 8 hours, max 101.7; Chills; body aches; Injection site pain; female patient who just got the COVID vaccine and is currently breastfeeding; female patient who just got the COVID vaccine and is currently breastfeeding; This is a spontaneous report from a contactable nurse (patient). This nurse reported for both mother and baby. This is maternal report.  A 30-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: Elt9899; expiration date: not known), via an unspecified route of administration on left arm on 19Dec2020 10:00 at single dose for covid-19 immunization, administered at workplace clinic. Medical history included childbirth in Jul2020 and currently (ongoing) breastfeeding. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Concomitant medications included norethindrone (NORETHINDRONE [NORETHISTERONE]) and unspecified prenatal vitamin (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested with covid-19 since the vaccination. On 19Dec2020 10:00, the female patient who just got the COVID vaccine and is currently breastfeeding. On 19Dec2020 18:00, the patient experienced fever for 8 hours, max 101.7; chills and body aches for 30 hours; and injection site pain for 48 hours. The reported events were non-serious. There was no treatment received for the events fever, chills, body aches, and injection site pain. The outcome of the event 'fever' was recovered on 20Dec2020 02:00 (for 8 hours), of event "chills and body aches" was recovered on 21Dec2020 00:00 (for 30 hours), and of event "injection site pain" was recovered on 21Dec2020 18:00 (for 48 hours).; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021011500 baby case
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fever for 8 hours, max 101.7; Chills; body aches; Injection site pain; female patient who just got the COVID vaccine and is currently breastfeeding; female patient who just got the COVID vaccine and is currently breastfeeding; This is a spontaneous report from a contactable nurse (patient). This nurse reported for both mother and baby. This is maternal report.  A 30-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: Elt9899; expiration date: not known), via an unspecified route of administration on left arm on 19Dec2020 10:00 at single dose for covid-19 immunization, administered at workplace clinic. Medical history included childbirth in Jul2020 and currently (ongoing) breastfeeding. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Concomitant medications included norethindrone (NORETHINDRONE [NORETHISTERONE]) and unspecified prenatal vitamin (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested with covid-19 since the vaccination. On 19Dec2020 10:00, the female patient who just got the COVID vaccine and is currently breastfeeding. On 19Dec2020 18:00, the patient experienced fever for 8 hours, max 101.7; chills and body aches for 30 hours; and injection site pain for 48 hours. The reported events were non-serious. There was no treatment received for the events fever, chills, body aches, and injection site pain. The outcome of the event 'fever' was recovered on 20Dec2020 02:00 (for 8 hours), of event "chills and body aches" was recovered on 21Dec2020 00:00 (for 30 hours), and of event "injection site pain" was recovered on 21Dec2020 18:00 (for 48 hours).; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021011500 baby case
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This is a spontaneous report from a contactable consumer (patient herself). A 68-year-old female patient received first dose of bnt162b2 (BNT162B2 also reported as Pfizer BioNTech, lot EL1284), via an unspecified route of administration in the left arm on 06Jan2021 10:30 at single dose for Covid-19 immunisation. The vaccine was administered in a hospital. Medical history included high blood pressure, asthma, neuropathy, hypothyroid. The patient was not diagnosed with Covid-19 prior to vaccination. She had not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included carvedilol, fluoxetine, levothyroxine sodium (LEVOXYL) and gabapentin. The patient previously took FLAGYL (metronidazole benzoate), PERCOCET (oxycodone hydrochloride;oxycodone terephthalate;paracetamol), dilaudid and had drug allergy. In the morning after vaccine (07Jan2021 08:30), she woke with mild dizziness and it was continuing through the morning so far. The outcome of event was not recovered.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site pruritus
Clinical narrative: felt a little itching around the injection site; she was itching from head to toe; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 43-year-old female patient (not pregnant) received her first dose of bnt162b2 (BNT162B2, also reported as COVID 19, brand Pfizer, lot EL1284), intramuscularly in the left arm on 06Jan2021 15:45 at single dose, for Covid-19 immunisation. She received the vaccine in a hospital. Medical history included allergy to lima beans, grapes, cucumbers, celery, melons, kiwi. No other vaccine in four weeks. No Covid and Covid test prior to vaccination. Concomitant medications included propranolol, escitalopram, spironolactone, cetirizine hydrochloride (ZYRTEC), ethinylestradiol, ferrous fumarate, norethisterone acetate (LARIN FE), biotin and sambucus nigra fruit (ELDERBERRY [SAMBUCUS NIGRA FRUIT]). The patient previously took CEFTIN (ceftriaxone) and sulfa and had drug allergy. The patient informed that once she got the shot (06Jan2021), she felt a little itching around the injection site a few minutes later. Later on that evening, she was itching from head to toe without any swelling or rash. No treatment was given. The patient recovered from the events.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Feeling jittery, Heart rate, Heart rate increased
Clinical narrative: palpitations; increased heart rate; jitteriness; cold sweats; chills; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration on  an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had palpitations, increased heart rate, jitteriness, cold sweats and chills on an unspecified date with outcome of unknown. The pharmacist asked for the opinion on what to do if the patient had a reaction to the first dose of the vaccine, based off the type of reaction.  Information on the batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: palpitations; increased heart rate; jitteriness; cold sweats; chills; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration on  an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had palpitations, increased heart rate, jitteriness, cold sweats and chills on an unspecified date with outcome of unknown. The pharmacist asked for the opinion on what to do if the patient had a reaction to the first dose of the vaccine, based off the type of reaction.  Information on the batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash/rash that broke out on both legs and now it's everywhere and especially legs; This is a spontaneous report from a contactable consumer wife reporting for her husband. A 70-year-old male patient received the first dose of (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknow), via an unspecified route of administration on unspecified date at SINGLE DOSE for COVID-19 immunization.  The patient medical history and concomitant medication was unknown. A day later he had a little rash that broke out on both legs and now it was everywhere and especially legs. It was up and down both legs on an unspecified date. Reporter asked if it was ok for the patient to take a prednisone pack that was prescribed to him for a rash he got after getting the first dose of the COVID vaccine. She reported that her husband went to urgent care for the rash all over and they prescribed prednisone and she was not sure if he should take it. Event outcome was unknown.  Information about Lot/Batch number is requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was a little ache, sore; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received the first dose and 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), route and dates were unknown, both at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient mentioned receiving both doses of the COVID-19 vaccine and feeling fine except that his arm was a little ache and sore on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Axillary pain, Lymphadenopathy, Muscle spasms, Myalgia
Clinical narrative: Muscles pains, with spasms; Muscles pains, with spasms; Nausea; Lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit.; Lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit.; Too weak to perform normal activities/slept for 2 days straight; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient (pregnant: No) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: El1284 and Expiration Date unknown) via intramuscular route of administration on 05Jan2021 11:00 AM (Left arm) at single dose on arm for COVID-19 immunization. Historical Vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: Eh9894) via intramuscular route of administration on 17Dec2020 05:00 PM (Left arm) at single dose for COVID-19 immunization. No other vaccine in four weeks. The patient's medical history included known allergy and None other medical history. The concomitant drug was reported as Birth control medication. On 06Jan2021 1:30 am the patient woke up with severe all over muscles pains, with spasms that Tylenol 1000mg did not resolve. The patient had nausea, lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit. The patient slept for 2 days straight, too weak to perform normal activities. The patient continued to have some symptoms 3 days later. No treatment received for the adverse events of nausea, lymphadenopathy, pain in armpit, slept for 2 days straight, too weak to perform normal activities. No COVID prior vaccination and no COVID tested post vaccination. The outcome of event was recovering.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Muscles pains, with spasms; Muscles pains, with spasms; Nausea; Lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit.; Lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit.; Too weak to perform normal activities/slept for 2 days straight; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient (pregnant: No) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: El1284 and Expiration Date unknown) via intramuscular route of administration on 05Jan2021 11:00 AM (Left arm) at single dose on arm for COVID-19 immunization. Historical Vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: Eh9894) via intramuscular route of administration on 17Dec2020 05:00 PM (Left arm) at single dose for COVID-19 immunization. No other vaccine in four weeks. The patient's medical history included known allergy and None other medical history. The concomitant drug was reported as Birth control medication. On 06Jan2021 1:30 am the patient woke up with severe all over muscles pains, with spasms that Tylenol 1000mg did not resolve. The patient had nausea, lymphadenopathy on the left side of my arm, chest, neck with pain in my armpit. The patient slept for 2 days straight, too weak to perform normal activities. The patient continued to have some symptoms 3 days later. No treatment received for the adverse events of nausea, lymphadenopathy, pain in armpit, slept for 2 days straight, too weak to perform normal activities. No COVID prior vaccination and no COVID tested post vaccination. The outcome of event was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Peripheral swelling
Clinical narrative: My arm is swollen; lymph node swelling; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient's arm was swollen and she would like more info on what to do and will it go away. Also stated that she would like to talk to an expert about lymph node swelling. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Dysgeusia, Fatigue, Laboratory test, Pain in extremity
Clinical narrative: arm is sore; Fatigue; eyes are still heavy; a metallic taste in her mouth; sleepy/eyes are still heavy/she is yawning a lot more; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), via an unspecified route of administration on 06Jan2021 at single dose in her left arm for covid-19 immunization. The patient had no medical history. There were no concomitant medications. The patient had no investigation assessment. It was reported that it had been 24 hours, she received her first bnt162b2 (reported as Pfizer COVID vaccine), yesterday (on 06Jan2021), and she was wondering, her arm was sore on 07Jan2021, which she thought was normal and fatigue on 06Jan2021, she got right away, she didn't know if that was normal, but she got a metallic taste in her mouth on 06Jan2021. It felt like a metallic taste when she swallows, a little metallic taste, yesterday (on 06Jan2021) was more than today, it was after the vaccine, about 7 hours after. She thought in her head, like the aluminum chewing gum, when kids chew it, it had a metallic taste, like the (company name withheld) wrapper she used to chew on it. Provides she was shrinking. Provide she was wearing stretch pants when providing weight. She Googled and didn't see the metallic taste, the only thing she saw with metallic taste is if you have the actual virus, she didn't have it, she was fine. Maybe it was all in her head. Arm was sore not right away, it built up, like when you stretch like with the flu shot, she lifted and it's sore, and she felt sleepy. It was like with the flu shot, it took a few days to go away. Last night on 06Jan2021, she was very sleepy, she was kind of sleepy, but it could be watching the Capitol and insanity, but she was yawning a lot more, her eyes felt heavy, she was ok, she had an appetite and is fine, she would drink (company name withheld) now. Thought she was peaking with it, she would go to sleep early today (07Jan2021), her eyes were still heavy, she wanted to close them and took a nap, but couldn't. It was like her saliva has a metallic taste in her mouth, it may be in her head, she googled to see side effects and when they start, it may be going soon, who knows, she was just wondering. The taste was worse yesterday (06Jan2021), and it wasn't IV or anything like that, the patient wanted to know how can that be. She had to go back on the 27th for her second dose. She had been tested and retested on an unspecified date, and it was offered for those 65 and over, and she was lucky to get an appointment. The outcome of the event metallic taste was recovering; the events fatigue and eyes heavy was not recovered; the outcome of the rest events was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: arm is sore; Fatigue; eyes are still heavy; a metallic taste in her mouth; sleepy/eyes are still heavy/she is yawning a lot more; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), via an unspecified route of administration on 06Jan2021 at single dose in her left arm for covid-19 immunization. The patient had no medical history. There were no concomitant medications. The patient had no investigation assessment. It was reported that it had been 24 hours, she received her first bnt162b2 (reported as Pfizer COVID vaccine), yesterday (on 06Jan2021), and she was wondering, her arm was sore on 07Jan2021, which she thought was normal and fatigue on 06Jan2021, she got right away, she didn't know if that was normal, but she got a metallic taste in her mouth on 06Jan2021. It felt like a metallic taste when she swallows, a little metallic taste, yesterday (on 06Jan2021) was more than today, it was after the vaccine, about 7 hours after. She thought in her head, like the aluminum chewing gum, when kids chew it, it had a metallic taste, like the (company name withheld) wrapper she used to chew on it. Provides she was shrinking. Provide she was wearing stretch pants when providing weight. She Googled and didn't see the metallic taste, the only thing she saw with metallic taste is if you have the actual virus, she didn't have it, she was fine. Maybe it was all in her head. Arm was sore not right away, it built up, like when you stretch like with the flu shot, she lifted and it's sore, and she felt sleepy. It was like with the flu shot, it took a few days to go away. Last night on 06Jan2021, she was very sleepy, she was kind of sleepy, but it could be watching the Capitol and insanity, but she was yawning a lot more, her eyes felt heavy, she was ok, she had an appetite and is fine, she would drink (company name withheld) now. Thought she was peaking with it, she would go to sleep early today (07Jan2021), her eyes were still heavy, she wanted to close them and took a nap, but couldn't. It was like her saliva has a metallic taste in her mouth, it may be in her head, she googled to see side effects and when they start, it may be going soon, who knows, she was just wondering. The taste was worse yesterday (06Jan2021), and it wasn't IV or anything like that, the patient wanted to know how can that be. She had to go back on the 27th for her second dose. She had been tested and retested on an unspecified date, and it was offered for those 65 and over, and she was lucky to get an appointment. The outcome of the event metallic taste was recovering; the events fatigue and eyes heavy was not recovered; the outcome of the rest events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pain in extremity
Clinical narrative: pain in both arms; muscle aches; flu like symptoms; This is a spontaneous report from a contactable physician patient from a Pfizer-sponsored program. A male patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medication included Johnson & Johnson (J&J) DNA vaccine. The patient participated in a J&J vaccine DNA trial 3-4 weeks ago and it had enough time to work. Trial was over. Then he got a call to get the Pfizer vaccine on holiday eve. Got the Pfizer vaccine too 12-14h post dose (unspecified date) had pain in both arms, muscle aches, flu like symptoms, no fever or pulmonary symptoms. Might not need to take a 2nd dose of Pfizer's vaccine because he had a reaction to it. The patient took both the J &J Vaccine and the Pfizer COVID vaccine and he wanted to know if they need to take the second dose of the Pfizer COVID vaccine. He participated in a randomized trial and he completed the trial and knew he got the J&J vaccine. On holiday Eve that his name came up on the list to get the Pfizer COVID vaccine and so he went and got it. He had the J&J vaccine 3 weeks earlier and so he went ahead and got the Pfizer one. Mentioned the J&J vaccine was the DNA vaccine and the Pfizer was the RNA and wanted to know if the second dose of the Pfizer COVID vaccine was needed. He did have significant flu like symptoms with the Pfizer COVID vaccine, which he knew that most people get, but if he didn't have to get the second dose he would prefer not to go through those flu like symptoms as before if he can help it. The outcome of events was unknown.  Information about batch/lot number has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Heart rate, Pain
Clinical narrative: headaches; tachycardia/fast heart beat; fever; body aches; joint pain/ joint ache; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration on 06Jan2021 at single dose for work. The patient's medical history and concomitant medications were reported as none. The patient reported events of fever, headaches, body aches, joint pain, tachycardia, on 07Jan2021. Patient developed fever in the night, 100.5 at 1-3 am. Then, developed body ache and especially joint ache. She had a bad headache from 2-3 am. She also experienced a fast heart beat that started around 2-3 am. She received the vaccine at work. She started taking the paracetamol (TYLENOL) which did pushed down her fever. She thought it helped her headache as well and it helped her heart rate. Her headache was controlled with paracetamol. So she could not tell if it was improving, persisting, or worsening. Her heart rate at around 2-3 am was 115bpm, after paracetamol it got down to 105 bpm. Therapeutic measures were taken as result of the events included paracetamol (TYLENOL). The outcome of the events fever and tachycardia was recovering, outcome of event headaches was unknown, outcome of the other evets was not recovered. The report was reported as non-serious.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia
Clinical narrative: headaches; tachycardia/fast heart beat; fever; body aches; joint pain/ joint ache; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration on 06Jan2021 at single dose for work. The patient's medical history and concomitant medications were reported as none. The patient reported events of fever, headaches, body aches, joint pain, tachycardia, on 07Jan2021. Patient developed fever in the night, 100.5 at 1-3 am. Then, developed body ache and especially joint ache. She had a bad headache from 2-3 am. She also experienced a fast heart beat that started around 2-3 am. She received the vaccine at work. She started taking the paracetamol (TYLENOL) which did pushed down her fever. She thought it helped her headache as well and it helped her heart rate. Her headache was controlled with paracetamol. So she could not tell if it was improving, persisting, or worsening. Her heart rate at around 2-3 am was 115bpm, after paracetamol it got down to 105 bpm. Therapeutic measures were taken as result of the events included paracetamol (TYLENOL). The outcome of the events fever and tachycardia was recovering, outcome of event headaches was unknown, outcome of the other evets was not recovered. The report was reported as non-serious.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lethargy, Lymphadenopathy, SARS-CoV-2 antibody test
Clinical narrative: Swollen lymph nodes at various times over 2 weeks. Consistent, intermittent headaches. Lethargy.; Consistent, intermittent headaches; Swollen lymph nodes at various times over 2 weeks. Consistent, intermittent headaches. Lethargy.; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received the first dose of BNT162B2 Lot number=EL1284, via an unspecified route of administration on 22Dec2020 11:15 at single dose in the left arm for COVID-19 immunization. Medical history included Allergies to Penicillin. Concomitant medication included melatonin, diphenhydramine hydrochloride (BENADRYL) and celecoxib (CELEXA). On 21Dec2020 19:00 (pending clarification), the patient experienced swollen lymph nodes at various times over 2 weeks, consistent, intermittent headaches and lethargy. The patient did not receive any treatment for the events. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab: negative on 04Jan2021. The outcome of the events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: diffuse rash started on abdomen spread to arms and back, no mucosal involvement, no resp symptoms, rash not painful or itchy; This is a spontaneous report from a contactable physician. A 44-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date were unknown) intramuscularly on 31Dec2020 at a single dose for COVID-19 immunization. The patient's medical history included gout and glaucoma, both from an unknown date and unknown if ongoing. The patient had no known allergies to medications, food, or other products. Concomitant medication included allopurinol; patient received allopurinol within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Jan2021, the patient experienced diffuse rash started on abdomen spread to arms and back, no mucosal involvement, no resp symptoms, rash not painful or itchy. Therapeutics measures were taken in response to the event; patient took Medrol pack. The outcome of the event at the time of last observation was not recovered. The report was considered as non-serious; the event did not result in death, was not life threatening, did not caused/prolonged hospitalization, was not disabling/ incapacitating, and did not caused any congenital anomaly/birth defect.  No follow-up attempts are possible. Information on lot/batch cannot be obtained. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Migraine, Myalgia, Pyrexia
Clinical narrative: Migraine; fever; muscle soreness; chills; issues staying asleep; shortness of breath; This is a spontaneous report from a contactable Other HCP (patient).  This 24-year-old male received the second  dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),LOT# EL0140 at right arm on 06Jan2021 02:15 PM at SINGLE DOSE for COVID-19 immunization. The patient received his first dose of the same vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on  16Dec2020  02:30 pm at right arm Lot # EK5730 .Medical history included : Ilioinguinal neuralgia and  Migraine without status migrainosus, not intractable.Patient had past drug allergy to Valacyclovir and Nsaids.No COVID prior vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital .The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received concomitant medications within 2 weeks of vaccination.On 07Jan2021 at 08:00 AM, upon second dosage of vaccine, the patient experienced Migraine, fever, muscle soreness, shortness of breath, chills and issues staying asleep. The events were assessed as non-serious. The patient had not been tested for COVID post vaccination. No treatment received for the events.The outcome of the events was recovering.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Migraine; fever; muscle soreness; chills; issues staying asleep; shortness of breath; This is a spontaneous report from a contactable Other HCP (patient).  This 24-year-old male received the second  dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),LOT# EL0140 at right arm on 06Jan2021 02:15 PM at SINGLE DOSE for COVID-19 immunization. The patient received his first dose of the same vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on  16Dec2020  02:30 pm at right arm Lot # EK5730 .Medical history included : Ilioinguinal neuralgia and  Migraine without status migrainosus, not intractable.Patient had past drug allergy to Valacyclovir and Nsaids.No COVID prior vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital .The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received concomitant medications within 2 weeks of vaccination.On 07Jan2021 at 08:00 AM, upon second dosage of vaccine, the patient experienced Migraine, fever, muscle soreness, shortness of breath, chills and issues staying asleep. The events were assessed as non-serious. The patient had not been tested for COVID post vaccination. No treatment received for the events.The outcome of the events was recovering.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: The injection site was red, raised, warm to the touch.; The injection site was red, raised, warm to the touch.; The injection site was red, raised, warm to the touch.; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 21-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EK9231/expiration date: not provided), via intramuscular route of administration, on 04Jan2021 01:00 PM (at the age of 21 years old) as a single dose in the left arm for COVID-19 vaccination. Relevant medical history included heart murmur. The patient has an allergy to sulfa. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unspecified date. Concomitant medication included atenolol, spironolactone, and alprazolam (XANAX). The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021 at 12:00 AM, the patient experienced the injection site was red, raised, warm to the touch. The patient did not receive any treatment for these events. The outcome of the events the injection site was red, raised, warm to the touch was recovering. Since the vaccination, the patient had not been tested for COVID-19.
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Ocular discomfort, Ocular hyperaemia, Photophobia, Vision blurred
Clinical narrative: pressure in the eye; photophobia; blurred vision; pain and redness in the eyes; pain and redness in the eyes; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Wednesday at around 3:40 PM (06Jan2021 15:40) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient went to the eye doctor due to pressure in the eye, photophobia, blurred vision, pain and redness in the eyes in Jan2021. The events outcome was unknown. The patient reported they were not listed as a side effect of the vaccine but she was wondering if there were any reports related to this?  Information on the batch number has been requested.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Blood test, Dizziness, Electrocardiogram, Hypertension
Clinical narrative: Left side face numbness; hypertension; tachycardia; lightheadedness; This is a spontaneous report from a contactable other healthcare professional (patient himself). A 36-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Elo140), intramuscularly at site of left arm at 11:15 on 19Dec2020 at single dose for COVID-19 immunization. Medical history included known allergies: environmental, sulfa. Concomitant medication included ibuprofen within 2 weeks of vaccination. The patient experienced left side face numbness, hypertension, tachycardia and lightheadedness, all at 10:00 on 05Jan2021. All events were identified as non-serious by reporter. The patient received lisinopril 10mg, electrocardiogram (EKG) and blood work for treatment. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Tachycardia
Clinical narrative: Left side face numbness; hypertension; tachycardia; lightheadedness; This is a spontaneous report from a contactable other healthcare professional (patient himself). A 36-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Elo140), intramuscularly at site of left arm at 11:15 on 19Dec2020 at single dose for COVID-19 immunization. Medical history included known allergies: environmental, sulfa. Concomitant medication included ibuprofen within 2 weeks of vaccination. The patient experienced left side face numbness, hypertension, tachycardia and lightheadedness, all at 10:00 on 05Jan2021. All events were identified as non-serious by reporter. The patient received lisinopril 10mg, electrocardiogram (EKG) and blood work for treatment. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Flushing, Headache, Nausea
Clinical narrative: gut wrenching nausea; stomach ache; flushed; dizzy; Headache; This is a spontaneous report from a contactable other HCP(patient). A 51 years old female patient received first dose BNT162B2(lot number EL0140), via an unspecified route of administration on 29Dec2020 08:00 at the 51 years old at Arm Left at single dose for COVID-19 immunization. The patient medical history was none. The concomitant medications were none. The patient had her first dose on 29Dec2020, she had no fever or chills and she got it at 8AM, and she woke up on 30Dec2020, and for the last 9 days when she wakes up, she was gut wrenchingly nauseated. It lasted like up to sometimes until noon, she still had a little nausea now, and it is almost noon there, and this comes along with being so nauseated. She was having a pretty moderate stomach ache on 30Dec2020, especially after eating, then she was really felt flushed and dizzy on 30Dec2020, but she thought because the nausea was so bad. She had a headache on 30Dec2020 and lasted for 5 days. She was not sick prior to the COVID vaccine. The outcome of the event Headache was recovered on 04Jan2021, the other events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient) Pfizer Sponsored Program.  A 34-year-old Female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 at 08:45 at single dose in right arm for COVID-19 immunisation at the age of 34-year-old. Lot number was EJ1685. Medical history included ongoing epilepsy. Concomitant medications included ongoing carbamazepine (TEGRETOL) for epilepsy. On 06Jan2021, the patient had shingles. The consumer was provided with medication, VALTREX and she was informed to take it at 1mg three times a day. The consumer was calling because she needed to know if she could get her second dose as she was scheduled to receive it on 08Jan2021. The patient did not recover from the event. Information on the lot/batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature decreased, Fatigue, Myalgia, Neck pain
Clinical narrative: Low grade temperature; myalgias; fatigue; neck pain; injection site tenderness; This is a spontaneous report from a contactable physician (patient herself). A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) intramuscular (right arm), on 05Jan2021 at 16:00, at a single dose, for COVID-19 immunization. The patient has no relevant medical history and has no known allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular (left arm), on 17Dec2020, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 05Jan2021 at 21:00, the patient experienced low-grade temperature, myalgias, fatigue, neck pain, and injection site tenderness. The patient did not receive treatment for the events. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Low grade temperature; myalgias; fatigue; neck pain; injection site tenderness; This is a spontaneous report from a contactable physician (patient herself). A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) intramuscular (right arm), on 05Jan2021 at 16:00, at a single dose, for COVID-19 immunization. The patient has no relevant medical history and has no known allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular (left arm), on 17Dec2020, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 05Jan2021 at 21:00, the patient experienced low-grade temperature, myalgias, fatigue, neck pain, and injection site tenderness. The patient did not receive treatment for the events. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Product prescribing error, Pruritus, Rash
Clinical narrative: 1st dose of the vaccine last 29Dec2020/she is already scheduled to take it next Friday; she felt kind of itchy; saw pink all over her body; broke out in a rash; This is a spontaneous report received from a contactable nurse (who is also the patient). A female patient of an unspecified age received her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number and expiry date not reported), via an unspecified route of administration, on 29Dec2020, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported to have received the 1st dose of the vaccine last 29Dec2020. After a few hours, she felt kind of itchy and saw pink all over her body and broke out in a rash for a few days. She mentioned that it was not anaphylaxis and is looking for recommendations if she can receive the 2nd dose of the vaccine as she is already scheduled to take it next Friday (15Jan2021, pending clarification). The outcome of the events was unknown.  Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: 1st dose of the vaccine last 29Dec2020/she is already scheduled to take it next Friday; she felt kind of itchy; saw pink all over her body; broke out in a rash; This is a spontaneous report received from a contactable nurse (who is also the patient). A female patient of an unspecified age received her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number and expiry date not reported), via an unspecified route of administration, on 29Dec2020, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported to have received the 1st dose of the vaccine last 29Dec2020. After a few hours, she felt kind of itchy and saw pink all over her body and broke out in a rash for a few days. She mentioned that it was not anaphylaxis and is looking for recommendations if she can receive the 2nd dose of the vaccine as she is already scheduled to take it next Friday (15Jan2021, pending clarification). The outcome of the events was unknown.  Information about batch/lot number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: right leg paresthesia; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of Pfizer COVID 19 vaccine and experienced right leg paresthesia on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, Chest X-ray normal, Full blood count normal, Intervertebral disc protrusion
Clinical narrative: right leg paresthesia; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of Pfizer COVID 19 vaccine and experienced right leg paresthesia on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal abnormal, Metabolic function test normal, Musculoskeletal disorder, Myalgia, Paraesthesia
Clinical narrative: right leg paresthesia; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of Pfizer COVID 19 vaccine and experienced right leg paresthesia on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.